Pakistan vs Poland: The number of people with susceptibility test result for rifampicin
Pakistan
91.93
in 2021
Poland
91.55
in 2021
Pakistan rank
63rd
Poland rank
65th
The number of people with susceptibility test result for rifampicin over time
- Pakistan
- Poland
How they compare
Pakistan currently reports 91.93 against 91.55 in Poland, a difference of 0.38.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Poland ahead.
Pakistan ranks 63rd and Poland ranks 65th of 146 countries.
Poland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Pakistan | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 43.98 | 89.97 | 45.99 | Poland |
| 2020s | 81.25 | 90.9 | 9.65 | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Pakistan or Poland?
- Pakistan, at 91.93 against 91.55 in Poland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Pakistan and Poland?
- 0.38, with Pakistan ahead.
- How many years of comparable data are there for Pakistan and Poland?
- 5 years are reported by both, from 2017 to 2021.
- How do Pakistan and Poland rank globally for the number of people with susceptibility test result for rifampicin?
- Pakistan ranks 63rd and Poland ranks 65th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.